Company profile · free preview
Stevanato Group S.p.A.
STVN · NYSE · Healthcare · Updated 11/18/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about Stevanato Group S.p.A.'s filings — free.
Create free accountStevanato Group S.p.A. return on capital (fiscal 2025)
ROIC
7.7%
Return on capital
7.6%
Return on equity
9.7%
Return on assets
5.7%
Gross margin
29.0%
Operating margin
16.8%
Net debt / EBITDA
1.13x
Stevanato Group S.p.A. insider buying and selling
Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-08-07 | Santel Luciano | Sale | 2,023 | $20.09 |
| 2026-08-07 | Dal Lago Marco | Sale | 4,209 | $20.09 |
| 2026-08-07 | Magistretti Elisabetta | Sale | 2,045 | $20.09 |
| 2026-06-15 | Balachandran Madhavan | Sale | 1,493 | $17.09 |
| 2026-06-15 | Flynn Karen | Sale | 1,493 | $17.09 |
| 2026-06-15 | FEDERICI WILLIAM J | Sale | 1,493 | $17.09 |
| 2026-06-15 | MOREL DONALD E JR | Sale | 1,493 | $17.09 |
SEC filings
No filings stored yet.
Ask anything about Stevanato Group S.p.A.'s filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeCompare STVN head-to-head
More Healthcare companies
Senseonics Holdings, Inc. SENSSight Sciences, Inc. SGHTSol-Gel Technologies Ltd. SLGLSiemens Healthineers AG SMMNYSOPHiA GENETICS S.A. SOPHNeuronetics, Inc. STIMStryker Corporation SYKTScan Therapeutics, Inc. TCRXTempus AI, Inc. TEMTeva Pharmaceutical Industries Limited TEVATransMedics Group, Inc. TMDXThermo Fisher Scientific TMO